Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02708940
Other study ID # IRB#14-001879
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 2016
Est. completion date December 2016

Study information

Verified date November 2023
Source University of California, Los Angeles
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This research project aims to evaluate the feasibility and effectiveness of a new approach to tailored mobile applications using the Chorus Participatory Mobile Framework. PHP and IOP program participants-patients and therapists--will be consented and enrolled by study staff. Study participants will be invited to workgroups specific to their program to discuss the usability of Chorus and be asked to complete surveys on demographics, satisfaction, self-efficacy, and involvement with Chorus and usability of the tool.


Description:

The Partial Hospitalization Program (PHP) and Intensive Outpatient Program (IOP) in the Neuropsychatric Hospital at UCLA provide psychiatric services for adults and children with acute mental illness. These include voluntary programs that support individuals in their recovery with the goal to assist patients in achieving the highest level of independence. Most programs operate Monday through Friday between four to eight hours a day. Recently, the PHP and IOP programs have decided to start including mobile messaging as a part of care, helping patients to feel supported even after they have left the hospital for the day. The purpose of this study is to evaluate the feasibility and effectiveness of their ongoing use of the Chorus Participatory Mobile Framework to support clinical care. Chorus is a framework and web application that allows users to rapidly create a broad range of automated text messaging (SMS), interactive voice (IVR), or mobile web applications using a simple and accessible visual interface without requiring any server programming. There will be two broad populations using Chorus: (1) programs (e.g. OCD Intensive Treatment Program) in which all participants will receive participatory mobile messaging and (2) programs (e.g. Adult Acute PHP) in which patients will be randomized to receive either participatory mobile messaging or no mobile messaging. Across all programs, Kandace Whiting and Armen Arevian will train PHP and IOP therapists starting with creating simple, basic, useful messaging content in Chorus to support patients in achieving program goals. Examples of messages include Cognitive Behavioral Therapy (CBT), symptom management, and stress management cues to patients in the Obsessive Compulsive Disorder Clinic, patients in the Adult Eating Disorder Clinic, and parents from The Achievement, Behavior, Cognition (ABC) Child Programs. All participating patients receiving participatory mobile messaging will work with program staff one-on-one to tailor SMS and IVR content and design based on their own preferences. By being able to personalize the messaging, the Chorus Participatory Mobile Framework meets the capacities and preferences of the users rather than a "one-size" approach requiring adaptation of the users to the technology. Both therapists and patients will be invited to up to bi-weekly, in-person workshops specific to their program to provide feedback and input. The goal of these workshops is to further develop and refine the novel mobile interventions based on stakeholder input. The Chorus Participatory Framework will be used during the workshops to develop and test the application in real-time. Workshops will be audio and/or video recorded to document the process.


Recruitment information / eligibility

Status Completed
Enrollment 150
Est. completion date December 2016
Est. primary completion date September 2016
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Patients (over the age of 18) or parents of patients who are minors (between the ages of 6 and 17) - Enrolled in PHP or IOP programs at Resnick Neuropsychiatric Hospital - Agree to participate (minors will be required to have parental consent) - Patient participants will need to be English speaking because text and IVR messages and workshops will be conducted in English. - Patient must have cellular phone that can receive text messages - All PHP and IOP staff are eligible and will be invited to participate in workshops and complete surveys. Exclusion Criteria: - Declines consent or is unwilling to participate in the study - Does not speak English. Language other than English is an exclusion given resources and capacity of the study - Patients without a cellular phone that can receive text messages - Not receiving texts or IVR messages from their program is an exclusion given that it is the intervention we are evaluating - Patients under the age of 6.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Participatory technology development
Creating mobile support tools by patients and their therapists
Usual Care
Usual care as part of the UCLA PHP and IOP programs

Locations

Country Name City State
United States UCLA Partial Hospitalization and Intensive Outpatient Programs Los Angeles California

Sponsors (1)

Lead Sponsor Collaborator
University of California, Los Angeles

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in homework completion rate the change in the degree to which patients complete tasks assigned to them by their provider as part of their treatment Collected on each program attendance day (up to daily), through discharge from program, an average of 12 weeks
Secondary length of stay length of stay (in terms of days and hours/day of program attendance) At discharge from program, an average of 12 weeks
Secondary time to discharge time to step down from partial hospitalization program to intensive outpatient program and time to discharge from program From admission to program until discharge from program, assessed up to 20 weeks
Secondary Number of patient visits to health care organizations outside of clinic the number of services that patients utilize outside of the clinic, including ED visits and inpatient hospitalizations. at patient disenrollment from study, approximately 3 months after discharge from program, up to 40 weeks
Secondary Types of health care services patients utilize outside of clinic the types of services that patients utilize outside of the clinic, including ED visits and inpatient hospitalizations. at patient disenrollment from study, approximately 3 months after discharge from program, up to 40 weeks
Secondary change in depression symptoms PHQ-9 to measure changes in depression symptoms Upon admission to program, at mid-point of stay in program, at discharge from program (may also be up to weekly during stay), an average of 12 weeks; and 3 months after discharge from programa
Secondary Change in Patient Treatment Self-Efficacy change patient treatment self-efficacy from week-to-week during program weekly during stay in program, through discharge from program, an average of 12 weeks
Secondary Difference in Patient Satisfaction with Program between Intervention vs Control groups comparing patient satisfaction with services and support between the intervention and control groups at discharge from program, an average of 12 weeks
Secondary Messaging Application Usability Weekly survey of patients in the intervention arm and all providers to assess the usability of the messaging application weekly during stay in program, through discharge from program, an average of 12 weeks
Secondary Patient Involvement in Message Development Completed by patients in the intervention arm and by provider for each patient in intervention arm to assess the extent of patient involvement in the development of message content and schedule, and use of messaging application weekly during stay in program, through discharge from program, an average of 12 weeks
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05777044 - The Effect of Hatha Yoga on Mental Health N/A
Recruiting NCT04977232 - Adjunctive Game Intervention for Anhedonia in MDD Patients N/A
Recruiting NCT04680611 - Severe Asthma, MepolizumaB and Affect: SAMBA Study
Recruiting NCT04043052 - Mobile Technologies and Post-stroke Depression N/A
Completed NCT04512768 - Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy N/A
Recruiting NCT03207828 - Testing Interventions for Patients With Fibromyalgia and Depression N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Completed NCT04476446 - An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives Phase 3
Recruiting NCT02783430 - Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease Phase 2/Phase 3
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Completed NCT04598165 - Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support N/A
Completed NCT03457714 - Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
Recruiting NCT05956912 - Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
Completed NCT05588622 - Meru Health Program for Cancer Patients With Depression and Anxiety N/A
Recruiting NCT05234476 - Behavioral Activation Plus Savoring for University Students N/A
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Enrolling by invitation NCT03276585 - Night in Japan Home Sleep Monitoring Study
Terminated NCT03275571 - HIV, Computerized Depression Therapy & Cognition N/A
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A